2/2015 Global Congress on Prostate Cancer Panel Discussion: “Turning the tables: putting the expert in the patient’s seat” http://library.mirrorsmed.org/sessions/turning-tables-putting-expert-patients-seat
Dr. Stacy Loeb MD, MSc, PhD (Hon)
Blog
Friday, October 23rd 2015
Comment
Global Congress on Prostate Cancer Lecture on Screening and Early Diagnosis of Prostate Cancer
2/2015 Global Congress on Prostate Cancer Lecture on Screening and Early Diagnosis of Prostate Cancer http://library.mirrorsmed.org/sessions/screening-and-early-diagnosis-prostate-cancer
Comment
Friday, October 23rd 2015
Comment
Cancer Research and Oncology Virtual Conference: Lecture on Active Surveillance: Trends in Use, Patient Selection & Monitoring
10/2015 Cancer Research and Oncology Virtual Conference: Lecture on Active Surveillance: Trends in Use, Patient Selection & Monitoring September 30, 2015 Lecture topic: Active Surveillance: Trends in Use, Patient Selection and Monitoring Category: prostate cancer Location: online
Comment
Friday, October 23rd 2015
Comment
Other Original Articles
Roobol MJ, van Vugt HA, Loeb S, Zhu X, Bul M, Bangma CH, van Leenders AG, Steyerberg EW, and Schroder FH. “Prediction of Prostate Cancer Risk: The Role of Prostate Volume and Digital Rectal Examination in the ERSPC Risk Calculators.” European Urology 2012; 61: 577-83. PMID: 22104592. Link: http://www.ncbi.nlm.nih.gov/pubmed/22104592
Comment
Friday, October 23rd 2015
Comment
Reviews/Editorials
Loeb S, Carlsson S, and Braithwaite RS. “Prostate Cancer: Modeling the Outcomes of Prostate Cancer Screening.” Nature Reviews Urology, March 2012; 13: 183-5. PMID: 224106678. Link: http://www.ncbi.nlm.nih.gov/pubmed/22410678
Comment
Thursday, October 22nd 2015
Comment
Key Papers
Bratt O, Folkvaljon Y, Hjalm Eriksson M, Akre O, Carlsson S, Drevin L, Franck Lissbrant I, Makarov D, Loeb S, Stattin P. “Undertreatment of Men in Their Seventies with High-risk Nonmetastatic Prostate Cancer.” European Urology 2015 epub. PMID: 25813688. Link: http://www.ncbi.nlm.nih.gov/pubmed/25813688 Using data from national Swedish registries, this study showed that many healthy men in… Read More
Comment
Thursday, October 22nd 2015
Comment
Key Papers
Mullins JK, Feng Z, Trock BJ, Epstein JI, Walsh PC, Loeb S. “The Impact of Anatomical Radical Retropubic Prostatectomy on Cancer Control: The 30-Year Anniversary.” Journal of Urology epub October 18, 2012. PMID: 23083655. Link: http://www.ncbi.nlm.nih.gov/pubmed/23083655 A total of 4,478 men underwent anatomical radical retropubic prostatectomy by Dr Patrick C. Walsh at the Johns Hopkins… Read More
Comment
Thursday, October 22nd 2015
Comment
Key Papers
Loeb S, Zhu X, Schroder FH, Roobol MJ. “Long-term radical prostatectomy outcomes among participants from the European Randomized Study of Screening for Prostate Cancer (ERSPC) Rotterdam.” BJU International epub Sept 21, 2012. PMID: 22998182. Link: http://www.ncbi.nlm.nih.gov/pubmed/22998182 This study compared the outcomes of prostate cancer treatment between men in the screening and control arms of the… Read More
Comment
Thursday, October 22nd 2015
Comment
Controversies in Management of High-Risk Prostate and Bladder Cancer.
Loeb S, Ribal MJ. “Controversies in Management of High-Risk Prostate and Bladder Cancer.” BJU International 2015 Nov; 116: 675. PMID: 26449166. Link: http://www.ncbi.nlm.nih.gov/pubmed/26449166
Comment
Thursday, October 22nd 2015
Comment
National Trends in the Utilization of Partial Nephrectomy Before and After the Establishment of AUA Guidelines for the Management of Renal Masses.
Bjurlin MA, Walter D, Taksler GB, Huang WC, Wysock JS, Sivarajan G, Loeb S, Taneja SS, Makarov DV. “National Trends in the Utilization of Partial Nephrectomy Before and After the Establishment of AUA Guidelines for the Management of Renal Masses.” Urology 2013; 82: 1283-9. PMID: 24295245. Link: http://www.ncbi.nlm.nih.gov/pubmed/24295245
Comment
Thursday, October 22nd 2015
Comment
Outcomes of a Bladder Cancer Screening Program Using Home Hematuria Testing and Molecular Markers.
Bangma CH, Loeb S, Susstra M, Zhu X, Bouazzaoui SE, Refos J, Van Der Keur KA, Tijn S, Franken CG, van Leenders GJ, Zwarthoff EC, Roobol MJ. “Outcomes of a Bladder Cancer Screening Program Using Home Hematuria Testing and Molecular Markers.” European Urology 2013 epub March 4. PMID: 23478169 Link: http://www.ncbi.nlm.nih.gov/pubmed/23478169
Comment
Thursday, October 22nd 2015
Comment
Is Prostate Specific Antigen Surveillance Necessary in Men with Benign Prostate Pathology Following Radical Cystoprostatectomy for Bladder Cancer?
Bivalacqua TJ, Loeb S, Pierorazio PM, Schoenberg MP, Partin AW, Guzzo TJ. “Is Prostate Specific Antigen Surveillance Necessary in Men with Benign Prostate Pathology Following Radical Cystoprostatectomy for Bladder Cancer?” Urologia Internationalis epub November 2010; 85: 466. Link: http://www.ncbi.nlm.nih.gov/pubmed/21071926
Comment
Thursday, October 22nd 2015
Comment
A Case of Gastrointestinal Stromal Tumor Diagnosed on Prostate Biopsy.
Loeb S, Lotan T, Thornton K, and Schoenberg MP. “A Case of Gastrointestinal Stromal Tumor Diagnosed on Prostate Biopsy.” Nature Clinical Practice Urology, December 2008 (epub). Link: http://www.ncbi.nlm.nih.gov/pubmed/19048005
Comment
Thursday, October 22nd 2015
Comment
Management of Distal Ureter in Laparoscopic Nephroureterectomy- A Comprehensive Review of Techniques.
Macejko AM, Pazona JF, Loeb S, Kimm S, and Nadler RB. “Management of Distal Ureter in Laparoscopic Nephroureterectomy- A Comprehensive Review of Techniques.” Urology 2008 (epub). Link: http://www.ncbi.nlm.nih.gov/pubmed/18602140
Comment
Thursday, October 22nd 2015
Comment
Thoracic Complications of Urological Laparoscopy: Correlation Between Radiographic Findings and Clinical Manifestations.
Zhao LC, Han JS, Loeb S, Tenggardjaja C, Rubenstein R, Smith ND, and Nadler RB. “Thoracic Complications of Urological Laparoscopy: Correlation Between Radiographic Findings and Clinical Manifestations.” J Endourol 2008; 22: 607. Link: http://www.ncbi.nlm.nih.gov/pubmed/18419207
Comment
Thursday, October 22nd 2015
Comment
Pathologic Findings and Clinical Outcomes of Patients Undergoing Retroperitoneal Lymph Node Dissection Following Multiple Chemotherapy Regimens for Metastatic Testicular Germ Cell Tumors.
Eggener SE, Carver BS, Loeb S, Kondagunta GV, Bosl GJ, and Sheinfeld J. “Pathologic Findings and Clinical Outcomes of Patients Undergoing Retroperitoneal Lymph Node Dissection Following Multiple Chemotherapy Regimens for Metastatic Testicular Germ Cell Tumors.” Cancer, February 2007; 109: 528. Link: http://www.ncbi.nlm.nih.gov/pubmed/17177200
Comment
Thursday, October 22nd 2015
Comment
The Use of BioGlue in Laparoscopic Partial Nephrectomy.
Nadler RB, Loeb S, and Vardi IY. “The Use of BioGlue in Laparoscopic Partial Nephrectomy.” Urology, August 2006; 68: 416. Link: http://www.ncbi.nlm.nih.gov/pubmed/16904466
Comment
Thursday, October 22nd 2015
Comment
A Prospective Study on Laparoscopic Radical Nephrectomy: Is Transperitoneal, Retroperitoneal, or Hand-Assisted the Best Approach?
Nadler RB, Loeb S, Clemens JQ, Batler RA, Gonzalez CM, and Vardi IY. “A Prospective Study on Laparoscopic Radical Nephrectomy: Is Transperitoneal, Retroperitoneal, or Hand-Assisted the Best Approach?” Journal of Urology, April 2006; 175: 1230. Link: http://www.ncbi.nlm.nih.gov/pubmed/16515966
Comment
Thursday, October 22nd 2015
Comment
Reviews/Editorials
Murphy DG, Loeb S. “Prostate Cancer: Growth of AS in the USA Signals Reduction in Overtreatment.” Nature Reviews Urology 2015 epub. PMID: 26390970. Link: http://www.ncbi.nlm.nih.gov/pubmed/26390970
Comment
Thursday, October 22nd 2015
Comment
Other Original Articles
Makarov DV, Loeb S, Magheli A, Zhao K, Humphreys E, Gonzalgo ML, Partin AW, and Han M. “Significance of Preoperative PSA Velocity in Men with Low Serum PSA and Normal DRE.” World Journal of Urology 2011; 29: 11. Link: http://www.ncbi.nlm.nih.gov/pubmed/21153643
Comment
Thursday, October 22nd 2015
Comment
Reviews/Editorials
Loeb S and Catalona WJ. “PSA Should Drive Doing Prostate Biopsies.” Urologic Oncology: Seminars and Original Investigations Jan-Feb 2012; 30: 1-2. PMID: 21458316. Link: http://www.ncbi.nlm.nih.gov/pubmed/21458316
Comment
Thursday, October 22nd 2015
Comment
XXVII Congreso Venezolano de Urología, Congreso de Actualización en Urología Oncológica
Lecture topic: Nuevas marcardores en el cáncer de próstata (en español) Category: prostate cancer Location: via Skype to Venezuela
Comment
Thursday, October 22nd 2015
Comment
Heinrich Warner Symposium
Hamburg, Germany. January 2015 Lecture Topics : Genomic and Epigenetic Variations in Prostate Cancer Category: Prostate Cancer
Comment
Thursday, October 22nd 2015
Comment
Visiting Professor at the Division of Urology at Albany Medical College
USA. October 2015 Lecture Topics: Markers in Prostate Cancer Screening and Active Surveillance, Social Media in Urology Categories: Prostate cancer, Social media
Comment
Thursday, October 22nd 2015
Comment
Urological Research Society meeting
Jerusalem, Israel. September 2015 Lecture Topic: Utilization of Active Surveillance Category: Prostate Cancer
Comment
Thursday, October 22nd 2015
Comment
American Urological Association New York Section Meeting
Lisbon, Portugal. September 10-12, 2015 Lecture Topic: Markers in Screening and Active Surveillance Category: Prostate Cancer
Comment
Thursday, October 22nd 2015
Comment
Florida Urological Society meeting
Florida, USA. September 2015 Lectures topics: 1) The Dilemma of an Elevated PSA: The Role of New Biomarkers to Determine When to Biopsy, 2) 4K Score, 3) Social Media in Urology Categories: Prostate Cancer, Social Media
Comment
Wednesday, October 21st 2015
Comment
Other Original Articles
Loeb S, Carter HB, Schaeffer EM, Kettermann A, Ferrucci L, and Metter EJ. “Distribution of PSA Velocity by Total PSA Levels: Data from the Baltimore Longitudinal Study of Aging.” Urology January 2011; 77: 143. Link: http://www.ncbi.nlm.nih.gov/pubmed/21195835
Comment
Wednesday, October 21st 2015
Comment
Other Original Articles
Ross AE, Loeb S, Landis P, Partin AW, Epstein JI, Kettermann A, Feng Z, Carter HB, and Walsh PC. “Prostate-specific antigen kinetics during follow-up are an unreliable trigger for intervention in a prostate cancer surveillance program.” Journal of Clinical Oncology 2010; 28: 2810. Link: http://www.ncbi.nlm.nih.gov/pubmed/20439642
Comment
Wednesday, October 21st 2015
Comment
Other Original Articles
Loeb S, Kan D, Yu X, Roehl KA, and Catalona WJ. “Preoperative Prostate Specific Antigen Doubling Time is Not a Useful Predictor of Biochemical Progression After Radical Prostatectomy.” Journal of Urology, May 2010; 183: 1816. Link: http://www.ncbi.nlm.nih.gov/pubmed/20303104
Comment
Wednesday, October 21st 2015
Comment
Reviews/Editorials
Loeb S, Trock BJ. “Re: Randomized Prostate Cancer Screening Trial: 20 Year Follow-up.” European Urology 2011; 60: 1306. PMID: 22054407. Link: http://www.europeanurology.com/article/S0302-2838%2811%2900989-4/fulltext/re-randomised-prostate-cancer-screening-trial-20-year-follow-up
Comment
Wednesday, October 21st 2015
Comment
Reviews/Editorials
Loeb S. “Invited Editorial Comment Re: Variable Prostate-Specific Antigen Management Patterns by Nonurologist Providers at a Tertiary Medical Center.” Urology August 2011; 78: 248. PMID: 21820564. Link: http://www.ncbi.nlm.nih.gov/pubmed/21820564
Comment
Wednesday, October 21st 2015
Comment
Reviews/Editorials
Loeb S. “Use of Empiric Antibiotics in the Setting of an Increased Prostate Specific Antigen: Pro.” Journal of Urology June 2011; 186: 17. PMID: 21571331. Link: http://www.ncbi.nlm.nih.gov/pubmed/21571331
Comment
Wednesday, October 21st 2015
Comment
Reviews/Editorials
Loeb S. “Germline Sequence Variants and Prostate Specific Antigen Interpretation.” Clinical Chemistry May 2011; 57: 662-3. PMID: 21411622. Link: http://www.ncbi.nlm.nih.gov/pubmed/21411622
Comment
Tuesday, October 20th 2015
Comment
Reviews/Editorials
Loeb S. Editorial Comment on “Prostate-Specific Antigen Density: Toward a Better Cutoff to Identify Better Candidates for Active Surveillance.” Urology 2014; 84: 371. Link: http://www.ncbi.nlm.nih.gov/pubmed/24925831
Comment
Tuesday, October 20th 2015
Comment
Reviews/Editorials
Loeb S, Carter HB. “Point: Impact of Prostate-Specific Antigen Velocity on Management Decisions and Recommendations.” Journal of the National Comprehensive Cancer Network 2013; 11: 281. PMID: 23486454 Link: http://www.ncbi.nlm.nih.gov/pubmed/23486454
Comment
Monday, October 19th 2015
Comment
Reviews/Editorials
Loeb S. “Prostate Health Index (PHI): Golden Bullet or Just Another Prostate Cancer Marker?” European Urology epub 2013 Feb 14. PMID: 23453055 Link: http://www.ncbi.nlm.nih.gov/pubmed/23453055
Comment
Monday, October 19th 2015
Comment
Other Original Articles
Le BV, Griffin CR, Loeb S, Carvalhal GF, Kan D, Baumann NA, and Catalona WJ. “[-2] Proenzyme prostate specific antigen is more accurate than total and free prostate specific antigen in differentiating prostate cancer from benign disease in a prospective prostate cancer screening study.” Journal of Urology 2010; 183: 1355. Link: http://www.ncbi.nlm.nih.gov/pubmed/20171670
Comment
Sunday, October 18th 2015
Comment
Reviews/Editorials
Loeb S. “Prostate Cancer: Prostate Health Index- Improving Screening in Men with a Positive Family History.” Nature Reviews in Urology 2013; 10: 497 Link: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3943368/
Comment
Sunday, October 18th 2015
Comment
Other Original Articles
Tosoian JJ, Loeb S, Kettermann A, Landis P, Elliot DJ, Epstein JI, Partin AW, Carter HB, and Sokoll LJ. “Accuracy of PCA3 Measurement in Predicting Short-Term Biopsy Progression in an Active Surveillance Program.” Journal of Urology, February 2010; 183: 534. Link: http://www.ncbi.nlm.nih.gov/pubmed/20006883
Comment